• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Jonathan T. Caranfa, PharmD

Latest:

Humanistic and Economic Burden of Hepatocellular Carcinoma: Systematic Literature Review

Worldwide, more than half a million new cases of hepatocellular carcinoma (HCC) are diagnosed annually. The incidence of HCC in the United States is rising with an estimated 31,000 new cases in 2018. Disease prognosis remains poor, with a 5-year survival rate across all disease stages estimated between 10%-20%, and 3% for those diagnosed with distant disease. Although morbidity is significant, especially among patients with advanced-stage disease, limited information exists on the humanistic and economic burden of HCC.


Oscar A. Wehmanen, MS

Latest:

Improving Influenza Immunization in Pregnant Women and Healthcare Workers

Influenza vaccination rates in pregnant women and healthcare workers were increased with standing orders, vaccine advocates, and educational activities on influenza immunization.




Brennan Spiegel, MD, MSHS

Latest:

Cost-Effectiveness of Pharmacist Postdischarge Follow-Up to Prevent Medication-Related Admissions

A multivariable sensitivity analysis conducted on a pharmacy follow-up program of high-risk patients demonstrated cost savings to hospitals in 98.3% of head-to-head trials across 1000 hypothetical hospitals.


Melissa Hamilton, MPH

Latest:

Oral Anticoagulant Discontinuation in Patients With Nonvalvular Atrial Fibrillation

The risk of discontinuation of oral anticoagulant therapy (both warfarin and direct oral anticoagulant therapies [DOACs]) among nonvalvular atrial fibrillation patients was high. Although the hazard ratio for discontinuation favors DOACs, it is unlikely that the small difference in discontinuation relative to warfarin is clinically meaningful.



Todd J. Osbeck, MM

Latest:

Health Plan Use of Immunization Information Systems for Quality Measurement

Health plans may benefit from using a state immunization information system as the primary data source for HEDIS and physician incentive and quality programs.


David S. Zingmond, MD, PhD

Latest:

Targeting a High-Risk Group for Fall Prevention: Strategies for Health Plans

This study evaluates different strategies to identify high fall risk among community-dwelling elders using a combination of easily obtainable administrative data and patient screening questions.


Bert R. Meijboom, PhD

Latest:

Accountable Care Organizations: How to Dress for Success

Accountable care organizations will be more successful in taking on accountability for patient outcomes when market and firm organization get a balanced treatment.



Phuoc Anh (Anne) Nguyen, PharmD, MS, BCPS

Latest:

Pharmacy Team Engagement in Navigating the Revenue Cycle for High-Cost Medications in Patients With Cancer

With the clinical and financial implications of high-cost medications, and their impact on health system revenue, it is of utmost importance for all key stakeholders to be engaged in the complex revenue cycle.



Verghese T. Cherian, MD

Latest:

Patients’ Expectations of Their Anesthesiologists

Understanding patients’ expectations, educating them about the role of an anesthesiologist, and involving them in decisions about their medical care can improve patient satisfaction.



Sean M. Devlin, MA

Latest:

Complementary and Alternative Medicine Provider Use and Expenditures by Cancer Treatment Phase

More than 26% of cancer patients see CAM providers, primarily for musculoskeletal problems; use does not vary by treatment phase, and associated expenditures are low.




Jeffrey C. Schneider, MD

Latest:

Functional Status and Readmissions in Unilateral Hip Fractures

Functional status is an important predictor of an acute care readmission in patients who have had a unilateral hip fracture.


Michael Genau, MS

Latest:

Safety Net Representation in Federal Payment and Care Delivery Reform Initiatives

Although safety net organizations are eligible for some two-thirds of federal payment reform programs, fewer than 20% of these programs directly target the safety net.



Kristina S. Boye, PhD

Latest:

Medication Adherence and Improved Outcomes Among Patients With Type 2 Diabetes

Adherence to glucose-lowering agents was associated with a significant reduction in use of acute care resources without any increased total medical costs.




Samar Hafida, MD

Latest:

CHAPTER 1. Clinical Guideline for Adults With Diabetes

From the Adult Diabetes and Clinical Research sections, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts.


Rachel DeVinney, MPH, CHES

Latest:

CKD Quality Improvement Intervention With PCMH Integration: Health Plan Results

A scalable chronic kidney disease (CKD) quality improvement intervention demonstrated feasibility, decreased hospitalization, and reduced costs. These preliminary results support innovation in CKD by commercial health plans.



Rufus Collea, MD

Latest:

Transitions in Cancer Care - Moving From Crisis Intervention to Care Planning and Management

As the American healthcare sector transitions towards value-based and patient-centered care models, New York Oncology Hematology has seen success in modernizing palliative care delivery, integrating social services with the overall care experience, and using the family meeting model to ensure families remain involved throughout the patient’s treatment process.



© 2025 MJH Life Sciences
AJMC®
All rights reserved.